We are live on ! Find out more
Stanley Druckenmiller

Stanley Druckenmiller Duquesne Family Office

AUM $3.38B
1-Year Est. Return 61.92%
 

Stanley Druckenmiller is the founder of Duquesne Family Office and one of the most closely watched macro investors of his generation. He first became widely known as lead portfolio manager of the Quantum Fund alongside George Soros, including during the famous 1992 bet against the British pound. After returning outside capital, he has continued to invest with a flexible, top-down approach that blends macroeconomic views with concentrated equity and commodity positions.

This Fund
S&P 500
This Quarter Est. Return
+13.95%
1 Year Est. Return
+61.92%
3 Year Est. Return
+280.57%
5 Year Est. Return
+393.65%
10 Year Est. Return
+4,147.23%
AUM
$2.95B
AUM Growth
+$34.9M
Cap. Flow
-$266M
Cap. Flow %
-9%
Top 10 Hldgs %
62.64%
Holding
97
New
33
Increased
11
Reduced
20
Closed
22

Top Buys

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$183M
2
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$113M
3
AVGO icon
Broadcom
AVGO
+$38.5M
4
ASND icon
Ascendis Pharma A/S
ASND
+$35.8M
5
NVT icon
nVent Electric
NVT
+$31.1M

Top Sells

Rank Stock Value
1
VST icon
Vistra
VST
+$190M
2
MSFT icon
Microsoft
MSFT
+$153M
3
KMI icon
Kinder Morgan
KMI
+$87.2M
4
MAA icon
Mid-America Apartment Communities
MAA
+$61.8M
5
OPCH icon
Option Care Health
OPCH
+$51.8M

Sector Composition

Rank Sector Weight
1 Technology 21.46%
2 Healthcare 21.04%
3 Consumer Discretionary 15.34%
4 Industrials 9.47%
5 Financials 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KEY icon
51
KeyCorp
KEY
$24.4B
$9.78M 0.33%
+583,900
New +$9.26M
FHN icon
52
First Horizon
FHN
$12.1B
$9.62M 0.33%
+619,700
New +$9.84M
ABCB icon
53
Ameris Bancorp
ABCB
$5.89B
$9.61M 0.33%
+154,000
New +$9.01M
FCNCA icon
54
First Citizens BancShares
FCNCA
$25.3B
$9.54M 0.32%
+5,183
New +$9.89M
YPF icon
55
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
$9.12M 0.31%
430,100
-208,335
-33% -$4.44M
SPRY icon
56
ARS Pharmaceuticals
SPRY
$612M
$7.79M 0.26%
+536,900
New +$6.39M
GEV icon
57
GE Vernova
GEV
$264B
$7.46M 0.25%
29,250
-267,818
-90% -$51.4M
SLN
58
Silence Therapeutics
SLN
$564M
$7.04M 0.24%
387,400
– –
ACLX
59
DELISTED
Arcellx
ACLX
$6.19M 0.21%
74,100
– –
TRP icon
60
TC Energy
TRP
$65.9B
$5.49M 0.19%
+115,400
New +$5.02M
SBUX icon
61
Starbucks
SBUX
$120B
$5.1M 0.17%
+52,305
New +$4.49M
XPO icon
62
XPO
XPO
$23.7B
$5M 0.17%
+46,500
New +$5.2M
PCVX icon
63
Vaxcyte
PCVX
$8.64B
$4.91M 0.17%
+42,965
New +$3.87M
WDC icon
64
Western Digital
WDC
$150B
$4.88M 0.17%
+94,469
New +$4.77M
NAMS icon
65
NewAmsterdam Pharma
NAMS
$3.34B
$4.77M 0.16%
+287,535
New +$4.97M
RARE icon
66
Ultragenyx Pharmaceutical
RARE
$2.55B
$4.75M 0.16%
+85,445
New +$4.35M
BCYC
67
Bicycle Therapeutics
BCYC
$292M
$4.3M 0.15%
190,200
– –
ARM icon
68
Arm
ARM
$302B
$3.09M 0.1%
+21,610
New +$3.07M
IHS icon
69
IHS Holding
IHS
$2.81B
$2.3M 0.08%
770,310
– –
TLSI icon
70
TriSalus Life Sciences
TLSI
$345M
$1.97M 0.07%
426,921
– –
PLTR icon
71
Palantir
PLTR
$413B
$1.55M 0.05%
41,710
-728,255
-95% -$22.4M
INSM icon
72
Insmed
INSM
$28.6B
$1.46M 0.05%
20,000
– –
NRIX icon
73
Nurix Therapeutics
NRIX
$2.65B
$993K 0.03%
44,200
– –
IVVD icon
74
Invivyd
IVVD
$218M
$583K 0.02%
571,425
– –
JOBY icon
75
Joby Aviation
JOBY
$8.55B
$113K ﹤0.01%
22,492
– –
1 2
3
4

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

Stanley Druckenmiller's Q3 2024 Portfolio in Review

As of Q3 2024, Stanley Druckenmiller held 97 positions worth $2.95B, up 1.2% from $2.92B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Stanley Druckenmiller withdrew a net $266M in Q3 2024, closing 22 positions and reducing 20 holdings. Its most notable exit was Option Care Health, an estimated $51.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Stanley Druckenmiller opened a new position in State Street SPDR S&P Regional Banking ETF worth $116M.

  • Stanley Druckenmiller's largest Q3 2024 buy was State Street SPDR S&P Regional Banking ETF: 2,053,323 shares worth $116M.
  • Stanley Druckenmiller added most to Natera in Q3 2024, an estimated $183M increase.
  • Stanley Druckenmiller's biggest Q3 2024 reduction was Vistra, cutting an estimated $190M.
  • Stanley Druckenmiller fully exited Option Care Health in Q3 2024, selling an estimated $51.8M.
  • Stanley Druckenmiller's ten largest holdings make up 63% of its $2.95B portfolio in Q3 2024.
  • Stanley Druckenmiller opened 33 new positions and closed 22 in Q3 2024.
  • Stanley Druckenmiller's portfolio value rose 1.2% quarter-over-quarter to $2.95B.

Based on Duquesne Family Office's 13F filing for Q3 2024, filed 14 Nov 2024.